Alexander Labrunerie & Co’s Eli Lilly LLY Stock Holding History

Alexander Labrunerie & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$793K	Sell	862 -38	-4%	-$38.5K	0.3%	51
2025 Q4	$967K	Buy	900 +4	+0.4%	+$3.83K	0.35%	43
2025 Q3	$684K	Sell	896 -125	-12%	-$93K	0.25%	53
2025 Q2	$796K	Buy	1,021 +11	+1%	+$8.55K	0.33%	49
2025 Q1	$834K	Buy	1,010 +27	+3%	+$22.5K	0.36%	47
2024 Q4	$759K	Sell	983 -28	-3%	-$23.2K	0.34%	48
2024 Q3	$896K	Sell	1,011 -56	-5%	-$50.3K	0.41%	42
2024 Q2	$966K	Sell	1,067 -10	-0.9%	-$8K	0.52%	37
2024 Q1	$838K	Buy	+1,077	New	+$766K	0.47%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alexander Labrunerie & Co's LLY Position: Q1 2026 in Review

Alexander Labrunerie & Co reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $38.5K and leaving 862 shares worth $793K. The position accounts for 0.3% of the portfolio, ranked #51.

Alexander Labrunerie & Co first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $967K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Alexander Labrunerie & Co held 862 shares of Eli Lilly worth $793K as of Q1 2026.
Alexander Labrunerie & Co sold 38 Eli Lilly shares in Q1 2026, an estimated $38.5K.
Eli Lilly made up 0.3% of Alexander Labrunerie & Co's portfolio in Q1 2026, its #51 holding.
Alexander Labrunerie & Co first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Alexander Labrunerie & Co's Eli Lilly position peaked at $967K in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q1 2026, filed 18 May 2026.